Previous Close | 976.60 |
Open | 979.20 |
Bid | 980.00 x 0 |
Ask | 980.60 x 0 |
Day's Range | 978.40 - 989.80 |
52 Week Range | 887.00 - 1,315.00 |
Volume | |
Avg. Volume | 3,692,058 |
Market Cap | 8.57B |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | 40.84 |
EPS (TTM) | 0.24 |
Earnings Date | Aug 01, 2024 |
Forward Dividend & Yield | 0.30 (3.10%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | 12.80 |
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip